Allarity Therapeutics Initiates Phase 2 Trial of IXEMPRA® in Europe for the Treatment of Metastatic Breast Cancer

    NEXT STORY
    Global Liver Institute Offering Multilingual Materials and Grants for International NASH Day on June 10
    PREV STORY
    Herborium® Group Inc. Skin Health Products to Enter $250 Million Pacific Asian Market
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    VBL Therapeutics Announces Positive Outcome of the Interim Analysis in the OVAL Phase 3 Ovarian Cancer Pivotal Study

    author_avatar
    NASDAQ Market News

    Ascendis Pharma A/S Reports Second Quarter 2020 Financial Results and Announces New Data from the Four-Week, Fixed Dose, Double-Blind Portion of the PaTH Forward Trial

    author_avatar
    NASDAQ Market News

    Federal Minister, Dr. Jane Philpott to open the National Health Leadership Conference in Vancouver on June 12, 2017

    OTTAWA, June 09, 2017 (GLOBE NEWSWIRE) -- Federal Health Minister, Dr. Jane Philpott, will ...

    author_avatar
    NASDAQ Market News